🔎 Trials Near Me

Gara Jalqabaatti › Kansera Urothelial (Cell Transitional) › North Carolina › Durham

Qorannoo klinikaalii Kansera Urothelial (Cell Transitional) Durham, NC keessatti

Qorannoo 8 Kansera Urothelial (Cell Transitional) f Durham fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Exelixis Clinical Site #12, Durham
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT05176483

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Namoota walitti qabaa jiraSadarkaa 2
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Miili 10 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT03866382

uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

Namoota walitti qabaa jiraQorannoo ilaalaa
  • The University of North Carolina Chapel Hill, Chapel Hill · Miili 10 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT05874921

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Namoota walitti qabaa jiraSadarkaa 1/2
  • Duke University Medical Center (location of scans), Durham
  • Duke University Medical Center - Duke University Hospital (location of scans), Durham
  • Duke University Medical Center, Durham
  • fi 1 dabalataa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07421700

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Namoota walitti qabaa jiraSadarkaa 2/3
  • Research Site, Chapel Hill · Miili 10 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT07129993

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

Namoota walitti qabaa jiraSadarkaa 2
  • UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill · Miili 10 fagaatti
  • UNC Lineberger Comprehensive Cancer Center / University of North Carolina, Chapel Hill · Miili 10 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ado-2026 · NCT04879329

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Massive Bio SYNERGY-AI site, Chapel Hill · Miili 10 fagaatti
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

A Study of NX-1607 in Adults With Advanced Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • University of North Carolina, Chapel Hill · Miili 10 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2025 · NCT05107674

Qorannoo Kansera Urothelial (Cell Transitional) magaalota biroo keessatti

Qorannoo biroo Durham keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.